BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26590405)

  • 1. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.
    Zhao M; Kim P; Mitra R; Zhao J; Zhao Z
    Nucleic Acids Res; 2016 Jan; 44(D1):D1023-31. PubMed ID: 26590405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of tumor suppressor genes based on gene ontology and the KEGG pathway.
    Yang J; Chen L; Kong X; Huang T; Cai YD
    PLoS One; 2014; 9(9):e107202. PubMed ID: 25207935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel ratio-metric features enable the identification of new driver genes across cancer types.
    Sudhakar M; Rengaswamy R; Raman K
    Sci Rep; 2022 Jan; 12(1):5. PubMed ID: 34997044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic Analysis of Circadian Expression of Oncogenes and Tumor Suppressor Genes.
    Salavaty A; Mohammadi N; Shahmoradi M; Naderi Soorki M
    Bioinform Biol Insights; 2017; 11():1177932217746991. PubMed ID: 29276378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BioMuta and BioXpress: mutation and expression knowledgebases for cancer biomarker discovery.
    Dingerdissen HM; Torcivia-Rodriguez J; Hu Y; Chang TC; Mazumder R; Kahsay R
    Nucleic Acids Res; 2018 Jan; 46(D1):D1128-D1136. PubMed ID: 30053270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenes and tumor suppressor genes: functions and roles in cancers.
    Dakal TC; Dhabhai B; Pant A; Moar K; Chaudhary K; Yadav V; Ranga V; Sharma NK; Kumar A; Maurya PK; Maciaczyk J; Schmidt-Wolf IGH; Sharma A
    MedComm (2020); 2024 Jun; 5(6):e582. PubMed ID: 38827026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FusionPDB: a knowledgebase of human fusion proteins.
    Kumar H; Tang LY; Yang C; Kim P
    Nucleic Acids Res; 2024 Jan; 52(D1):D1289-D1304. PubMed ID: 37870473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MACC: a visual interactive knowledgebase of metabolite-associated cell communications.
    Gao J; Mo S; Wang J; Zhang M; Shi Y; Zhu C; Shang Y; Tang X; Zhang S; Wu X; Xu X; Wang Y; Li Z; Zheng G; Chen Z; Wang Q; Tang K; Cao Z
    Nucleic Acids Res; 2024 Jan; 52(D1):D633-D639. PubMed ID: 37897362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CanGeneBase (CGB)--a database on cancer related genes.
    Kumar GR; Subazini TK; Subha K; Rajadurai CP; Prabakar L
    Bioinformation; 2009 Jul; 3(10):422-4. PubMed ID: 19759863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. spongeScan: A web for detecting microRNA binding elements in lncRNA sequences.
    Furió-Tarí P; Tarazona S; Gabaldón T; Enright AJ; Conesa A
    Nucleic Acids Res; 2016 Jul; 44(W1):W176-80. PubMed ID: 27198221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DriverDBv2: a database for human cancer driver gene research.
    Chung IF; Chen CY; Su SC; Li CY; Wu KJ; Wang HW; Cheng WC
    Nucleic Acids Res; 2016 Jan; 44(D1):D975-9. PubMed ID: 26635391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer prevention as part of precision medicine: 'plenty to be done'.
    Stewart BW; Bray F; Forman D; Ohgaki H; Straif K; Ullrich A; Wild CP
    Carcinogenesis; 2016 Jan; 37(1):2-9. PubMed ID: 26590901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer.
    Douma KF; Smets EM; Allain DC
    Fam Cancer; 2016 Apr; 15(2):341-50. PubMed ID: 26590592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs.
    Gohlke BO; Nickel J; Otto R; Dunkel M; Preissner R
    Nucleic Acids Res; 2016 Jan; 44(D1):D932-7. PubMed ID: 26590406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic dissection of dysregulated transcription factor-miRNA feed-forward loops across tumor types.
    Jiang W; Mitra R; Lin CC; Wang Q; Cheng F; Zhao Z
    Brief Bioinform; 2016 Nov; 17(6):996-1008. PubMed ID: 26655252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.
    Andor N; Graham TA; Jansen M; Xia LC; Aktipis CA; Petritsch C; Ji HP; Maley CC
    Nat Med; 2016 Jan; 22(1):105-13. PubMed ID: 26618723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach.
    Zhao J; Cheng F; Wang Y; Arteaga CL; Zhao Z
    Mol Cell Proteomics; 2016 Feb; 15(2):642-56. PubMed ID: 26657081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts.
    Paraskevopoulou MD; Vlachos IS; Karagkouni D; Georgakilas G; Kanellos I; Vergoulis T; Zagganas K; Tsanakas P; Floros E; Dalamagas T; Hatzigeorgiou AG
    Nucleic Acids Res; 2016 Jan; 44(D1):D231-8. PubMed ID: 26612864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Thyroid Nodular Disease: Current Cytopathology Classifications and Genetic Testing.
    Kuo LE; Kelz RR
    Surg Oncol Clin N Am; 2016 Jan; 25(1):1-16. PubMed ID: 26610771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
    Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
    Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.